logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
G

Giuseppe Tirino

azienda ospedaliero universitaria careggi
H指数:14
被引数:582
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immunotherapy in Penile Squamous Cell Carcinoma: Present or Future? Multi-Target Analysis of Programmed Cell Death Ligand 1 Expression and Microsatellite Instability
FRONTIERS IN MEDICINE
IF3
2022-05-0316
OAAI
Montella, Marco; Sabetta, Rosalaura; Ronchi, Andrea; De Sio, Marco; Arcaniolo, Davide; De Vita, Ferdinando; Tirino, Giuseppe; Caputo, Alessandro; D'Antonio, Antonio; Fiorentino, Francesco; Facchini, Gaetano; Di Lauro, Giovanni; Perdona, Sisto; Ventriglia, Jole; Aquino, Gabriella; Feroce, Florinda; Dos Reis, Rodolfo Borges; Neder, Luciano; Brunelli, Matteo; Franco, Renato; Marino, Federica Zito
Results of the observational prospective RealFLOT study
BMC CANCER
IF3.4
2021-10-0825
OAAI
Giommoni, Elisa; Lavacchi, Daniele; Tirino, Giuseppe; Fornaro, Lorenzo; Iachetta, Francesco; Pozzo, Carmelo; Satolli, Maria Antonietta; Spallanzani, Andrea; Puzzoni, Marco; Stragliotto, Silvia; Sisani, Michele; Formica, Vincenzo; Giovanardi, Filippo; Strippoli, Antonia; Prisciandaro, Michele; Di Donato, Samantha; Pompella, Luca; Pecora, Irene; Romagnani, Alessandra; Fancelli, Sara; Brugia, Marco; Pillozzi, Serena; De Vita, Ferdinando; Antonuzzo, Lorenzo
Adjuvant Treatment in Pancreatic Cancer: Shaping the Future of the Curative Setting
FRONTIERS IN ONCOLOGY
IF3.3
2021-08-1616
OAAI
Pappalardo, Annalisa; Giunta, Emilio Francesco; Tirino, Giuseppe; Pompella, Luca; Federico, Piera; Daniele, Bruno; De Vita, Ferdinando; Petrillo, Angelica
Durable Complete Radiological Response to Nivolumab in Two Heavily Pretreated Western Elderly Patients With Metastatic Gastric Cancer: A Case Report
FRONTIERS IN ONCOLOGY
IF3.3
2020-02-172
OAAI
Tirino, Giuseppe; Petrillo, Angelica; Pompella, Luca; Pappalardo, Annalisa; Laterza, Maria Maddalena; Panarese, Iacopo; Sabetta, Rosalaura; Franco, Renato; Galizia, Gennaro; Ciardiello, Fortunato; De Vita, Ferdinando
Systemic-inflammation-based score can predict prognosis in metastatic gastric cancer patients before first-line chemotherapy
FUTURE ONCOLOGY
IF2.6
2018-07-0315
PREAI
Petrillo, Angelica; Laterza, Maria Maddalena; Tirino, Giuseppe; Pompella, Luca; Ventriglia, Jole; Pappalardo, Annalisa; Famiglietti, Vincenzo; Martinelli, Erika; Ciardiello, Fortunato; Orditura, Michele; Galizia, Gennaro; De Vita, Ferdinando
Ramucirumab as Second-Line Therapy in Metastatic Gastric Cancer: Real-World Data from the RAMoss Study
TARGETED ONCOLOGY
IF4
2018-03-2731
PREAI
Di Bartolomeo, Maria; Niger, Monica; Tirino, Giuseppe; Petrillo, Angelica; Berenato, Rosa; Laterza, Maria Maddalena; Pietrantonio, Filippo; Morano, Federica; Antista, Maria; Lonardi, Sara; Fornaro, Lorenzo; Tamberi, Stefano; Giommoni, Elisa; Zaniboni, Alberto; Rimassa, Lorenza; Tomasello, Gianluca; Sava, Teodoro; Spada, Massimiliano; Latiano, Tiziana; Bittoni, Alessandro; Bertolini, Alessandro; Proserpio, Ilaria; Bencardino, Katia Bruna; Graziano, Francesco; Beretta, Giordano; Galdy, Salvatore; Ventriglia, Jole; Scagnoli, Simone; Spallanzani, Andrea; Longarini, Raffaella; De Vita, Ferdinando
Neutrophil to lymphocyte ratio is a predictor of outcome in metastatic pancreatic cancer patients (MPC) treated with nab-paclitaxel and gemcitabine
ANNALS OF ONCOLOGY
IF65.4
2016-10-010
OAAI
Ventriglia, J.; Petrillo, A.; Huerta, M.; Laterza, M. M.; Savastano, B.; Gambardella, V.; Tirino, G.; Pompella, L.; Diana, A.; Febbraro, A.; Troiani, T.; Orditura, M.; Cervantes, A.; Ciardiello, F.; De Vita, F.
Prognostic implications of baseline neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) in metastatic gastric cancer (GC) patients
ANNALS OF ONCOLOGY
IF65.4
2016-10-011
OAAI
Petrillo, A.; Laterza, M. M.; Ventriglia, J.; Savastano, B.; Tirino, G.; Pompella, L.; Martinelli, E.; Morgillo, F.; Orditura, M.; Ciardiello, F.; De Vita, F.
Taselisib, a selective inhibitor of PIK3CA, is highly effective on PIK3CA-mutated and HER2 amplified gastric cancer (GC) cell lines
ANNALS OF ONCOLOGY
IF65.4
2016-09-010
OAAI
Laterza, M. M.; Belli, V.; Ciaramella, V.; Martinelli, E.; Morgillo, F.; Ventriglia, J.; Savastano, B.; Petrillo, A.; Tirino, G.; Pompella, L.; Diana, A.; Orditura, M.; Ciardiello, F.; De Vita, F.
GDC-0980, a novel PI3K/mTOR kinase inhibitor, is effective in HER2 positive gastric cancer (GC) cell lines resistant to Trastuzumab
ANNALS OF ONCOLOGY
IF65.4
2016-09-011
OAAI
Ventriglia, J.; Laterza, M. M.; Capasso, A.; Belli, V.; Savastano, B.; Petrillo, A.; Tirino, G.; Pompella, L.; Diana, A.; Orditura, M.; Ciardiello, F.; De Vita, F.
The combination of GDC-0980, a PI3K/mTOR kinase inhibitor and BAY-86-9766, a MEK inhibitor is able to induce cell growth inhibition of HER2 positive Trastuzumab resistant gastric cancer cell lines
ANNALS OF ONCOLOGY
IF65.4
2016-09-011
OAAI
Savastano, B.; Laterza, M. M.; Capasso, A.; Belli, V.; Ventriglia, J.; Petrillo, A.; Tirino, G.; Pompella, L.; Morgillo, F.; Martinelli, E.; Orditura, M.; Ciardiello, F.; De Vita, F.
Baseline neutrophil-lymphocyte ratio as a prognostic factor for patients with resectable gastric cancer undergoing adjuvant chemotherapy
EUROPEAN JOURNAL OF CANCER
IF7.1
2015-09-010
PREAI
Laterza, M. M.; Petrillo, A.; Ventriglia, J.; Fabozzi, A.; Savastano, B.; Tirino, G.; Orditura, M.; Diana, A.; Ciardiello, F.; De Vita, F.
Baseline neutrophil-lymphocyte ratio as a prognostic factor for patients with resectable gastric cancer undergoing adjuvant chemotherapy
ANNALS OF ONCOLOGY
IF65.4
2015-06-010
OAAI
Laterza, M. M.; Petrillo, A.; Ventriglia, J.; Savastano, B.; Diana, A.; Tirino, G.; Martinelli, E.; Orditura, M.; Ciardiello, F.; de Vita, F.

研究方向

暂未获取到该数据
A
Angelica Petrillo
H 指数:24论文数:146被引数:1,883
M
Maria Maddalena Laterza
H 指数:13论文数:71被引数:774
J
Jole Ventriglia
H 指数:18论文数:66被引数:893
F
Ferdinando De Vita
H 指数:54论文数:353被引数:1.0万
L
Luca Pompella
H 指数:12论文数:38被引数:526
F
Fortunato Ciardiello
H 指数:107论文数:1,034被引数:6.4万
B
B. Savastano
H 指数:5论文数:48被引数:261
M
Michele Orditura
H 指数:54论文数:330被引数:9,203
A
Anna Diana
H 指数:22论文数:97被引数:1,727
B
Belli, V.
H 指数:0论文数:13被引数:0